Protara Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Protara Therapeutics, Inc. (TARA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $4.22 million as of 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2025-05-08
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $4.22M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $6.74M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $20.00K.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $4.80.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2025-03-31 | $4.22M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $6.74M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $20.00K 10-K · filed 2025-03-05 | |
| 2022-12-31 | $4.80 10-K · filed 2023-03-08 | |
| 2021-12-31 | $12.60 10-K · filed 2023-03-08 | |
| 2020-12-31 | $696.00K 10-K · filed 2022-03-09 | |
| 2018-12-31 | $404.00K 10-K · filed 2020-03-20 | |
| 2018-09-30 | $130.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $614.00K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $678.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $121.00K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $140.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $45.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $64.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $124.00K 10-K · filed 2018-03-14 | |
| 2016-09-30 | $5.81M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $4.47M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $4.45M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $15.71M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $13.06M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $19.77M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $9.63K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $7.71M 10-K · filed 2016-03-14 | $7.71K 10-K · filed 2015-03-20 |
| 2014-09-30 | $8.72M 10-Q · filed 2014-11-25 | |
| 2013-12-31 | $7.71M 10-Q · filed 2015-11-12 | $1.63M 10-Q · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |